Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDNF Protéine

CDNF Origine: Humain Hôte: CHO Cells Recombinant WB, SDS, CC, in vivo Active
N° du produit ABIN1405917
  • Antigène Voir toutes CDNF Protéines
    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Origine
    • 4
    • 4
    • 2
    Humain
    Source
    • 7
    • 2
    • 1
    CHO Cells
    Application
    Western Blotting (WB), SDS-PAGE (SDS), Cell Culture (CC), In vivo Studies (in vivo)
    Attributs du produit
    Biological properties: Protein is biologically active. Suitable for cell culture and in vivo testing. Biological activity of human CDNF was tested in rat 6-OHDA model of Parkinson’s disease and shown to be both neuroprotective and neurorestorative (for methods see: Lindholm et al. 2007, Voutilainen et al. 2011)
    Purification
    Purified by ion-exchange chromatography and gel-filtration from serum-free CHO growth media.
    Protein is sterile-filtrated through 0.22 µg filter.
    Purified human CDNF is characterized as homogenous material by mass-spectroscopy.
    niveau d'endotoxine
    Less than 1EU/µg of protein as determined by LAL method
    Top Product
    Discover our top product CDNF Protéine
  • Commentaires

    Synonyms: Cerebral dopamine neurotrophic factor - CDNF, ARMETL1.

    Restrictions
    For Research Use only
  • Concentration
    1 mg/ml Concentration of the protein is determined by BCA Protein Analysis kit (Pierce). BSA was used as a standard
    Buffer
    PBS pH 7.5
    Conseil sur la manipulation
    Recommended to aliquot into smaller quantities. Avoid repeated freeze-thaw cycles.
    Stock
    -80 °C
  • Antigène
    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
    Autre désignation
    CDNF (CDNF Produits)
    Sujet
    CDNF is a trophic factor for midbrain dopamine neurons in vivo. It prevents the 6-OHDA- (Lindholm et al. 20007, Voutilainen et al., 2011) and MPTP-induced degeneration (Airavaara et al., 2012) of dopamine neurons in rodent models of Parkinson’s disease. When administered after 6-OHDA or MPTP –lesioning it restores the dopaminergic function and prevents degeneration of dopamine neurons in substantia nigra pars compacta.
    Poids moléculaire
    Approximately 18.5 kDa, a single non-glycosylated polypeptide chain containing 163 amino acids.
    UniProt
    Q49AH0
Vous êtes ici:
Blank
Blank
Support technique
Close menu